Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Korsana Biosciences, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −1 vs. Q2 2024
- Shares held
- 1.04M
- +8.10K (+0.8%) vs. Q2 2024
- Total value
- $2.70M
- +$324.4K (+13.7%) vs. Q2 2024
- New holders
- 2
- 1 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $11.2M |
| Q1 2026 | 17 | $249.0K |
| Q4 2025 | 19 | $376.3K |
| Q3 2025 | 17 | $595.4K |
| Q2 2025 | 17 | $1.06M |
| Q1 2025 | 18 | $931.7K |
| Q4 2024 | 19 | $1.23M |
| Q3 2024 | 15 | $2.70M |
| Q2 2024 | 17 | $2.41M |
| Q1 2024 | 15 | $3.42M |
| Q4 2023 | 15 | $3.58M |
| Q3 2023 | 17 | $3.66M |
| Q2 2023 | 18 | $4.10M |
| Q1 2023 | 34 | $8.95M |
| Q4 2022 | 40 | $13.7M |
| Q3 2022 | 38 | $18.3M |
| Q2 2022 | 41 | $11.5M |
| Q1 2022 | 50 | $25.6M |
| Q4 2021 | 56 | $40.7M |
| Q3 2021 | 62 | $75.8M |
| Q2 2021 | 68 | $96.0M |
| Q1 2021 | 71 | $62.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Korsana Biosciences, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Slate Path Capital LP | 357,880 | $926.9K | 0.02% | 00.0% | Unchanged |
| MFN Partners Management, LP | 169,460 | $437.2K | 0.01% | 00.0% | Unchanged |
| Tyndall Capital Partners L P | 164,777 | $426.8K | 100.00% | 00.0% | Unchanged |
| FMR LLC | 157,636 | $406.7K | 0.00% | −3,783−2.3% | Reduced |
| Siren, L.L.C. | 116,155 | $300.8K | 0.02% | +116,155 | New |
| Geode Capital Management, LLC | 33,908 | $87.5K | 0.00% | −70−0.2% | Reduced |
| Vanguard Group Inc | 23,490 | $60.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 16,797 | $43.5K | 0.00% | +16,797 | New |
| Tower Research Capital LLC (TRC) | 1,078 | $2.79K | 0.00% | −386−26.4% | Reduced |
| Morgan Stanley | 649 | $1.68K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 540 | $1.39K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 145 | $376 | 0.00% | −2,561−94.6% | Reduced |
| Activest Wealth Management | 100 | $259 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 23 | $59 | 0.00% | +7+43.8% | Added |
| Northwestern Mutual Wealth Management Co | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −117,643−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −416−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |